Astonea Labs IPO Peer Comparison
Astonea Labs Ltd peer comparison with similar listed entities. (As on March 28, 2024)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|
| Astonea Labs Ltd | 5.01 | 5.01 | 15.75 | | 31.83 | 9.00 | Restated |
| Beta Drugs Limited | 37.90 | 37.90 | 163.43 | 49.00 | 23.19 | 11.39 | Consolidated |
Source:
- All the financial information for listed peer Company mentioned above is taken as on March 31, 2024 (Audited result on consolidated basis) available on the website of NSE dated April 23, 2025 to compute the corresponding financial ratios.
- P/E ratios for the above peer company is based on closing market prices of equity shares on NSE dated April 23, 2025 divided by the Basic and Diluted EPS as at March 31, 2024
- Basic and Diluted EPS refers to the Basic and Diluted EPS sourced from the available financial data as on March 31, 2024 of the listed peer company.
- Return on Net Worth (%) for the listed peer company has been computed based on the Net Profit After Tax for the year ended March 31, 2024, divided by Total Equity as on March 31, 2024.
- NAV per share for the listed peer company is computed as the net worth on March 31, 2024, divided by the outstanding number of equity shares on March 31, 2024.
